Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/investing.ico', homepage_url='https://www.investing.com/', logo_url='https://s3.massive.com/public/assets/news/logos/investing.png', name='Investing.com')•2026-02-24
Hinge Health’s AI Moat Might Be Its Patient Movement DataHNGE — Hinge Health Inc
NYSE · Health Care · Health Care
$44.76-9.94%Market cap2.18B
- Latest Close
- $44.76
- 30-Day Move
- -9.9%
- Market Cap
- $2.2B
- Shares Outstanding
- 78,760,000
- P/B Ratio
- 9.66
- ROE
- -139.5%
Analyst consensus: Buy · 23 analysts
NYSE:HNGEHealth Care / Health CareDelayed public snapshot
Hinge Health Inc
A read-only Alphactor snapshot forHinge Health Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-22
Topline snapshot
Latest Close
$44.76
30-Day Move
-9.9%
Market Cap
$2.2B
Shares Outstanding
78,760,000
P/B Ratio
9.66
ROE
-139.5%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$44.76
-9.9%last 90 delayed daily bars
Market cap$2.2B
90D High
$51.15
90D Low
$30.08
Avg Volume
1,085,615
What stands out
Gross margin is running at 79.7%, which gives a quick read on operating quality before you open the full model.
Net margin is -89.9%, useful for comparing HNGE against peers in Health Care.
HNGE is down 9.9% over the last 30 trading days shown on this page.
Latest operating income is $27M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$90.34
Rule of 40
78.7%
Dark Pool Short %
30.6%
Fundamentals snapshot
Latest Close
$44.76
30-Day Move
-9.9%
Market Cap
$2.2B
Shares Outstanding
78,760,000
P/B Ratio
9.66
ROE
-139.5%
ROA
-70.9%
Gross Margin
79.7%
Operating Margin
-92.9%
Net Margin
-89.9%
Debt / Equity
0
Current Ratio
1.47
Latest Revenue
$171M
Financial statement snapshot
Revenue
$171M
Gross Profit
$144M
Operating Income
$27M
Net Income
$32M
Gross Margin
7965.0%
Net Margin
-8986.0%
Current Ratio
1.47
Debt / Equity
0.00
Valuation snapshot
Fair Value
$90.34
Upside / Downside
+101.8%
Signal
Undervalued
Implied Growth
-0.7%
DCF
$140.83
EV/Rev
$39.86
Growth Assumption
41.7%
Discount Rate
9.0%
Terminal Growth
2.0%
Base FCF
$165M
Valuation spread
Current Price
$44.76
Composite Fair Value
$90.34
DCF
$140.83
EV/Rev
$39.86
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative growth / decline priced in
Quality snapshot
Altman Z
0.23
Distress
Piotroski
5
Moderate (4-6)
Cash Conversion
-0.32x
Rule of 40
78.7%
Elite
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2023-12-31 | $293M | $-131M | $-108M | $-69M |
| 2024-12-31 | $390M | $-32M | $-12M | $45M |
| 2025-12-31 | $588M | $-546M | $-528M | $165M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Publisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/themotleyfool.ico', homepage_url='https://www.fool.com/', logo_url='https://s3.massive.com/public/assets/news/logos/themotleyfool.svg', name='The Motley Fool')•2026-02-20
The High‑Growth Healthcare Stock Early Investors Will Brag About for the Next DecadePublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/themotleyfool.ico', homepage_url='https://www.fool.com/', logo_url='https://s3.massive.com/public/assets/news/logos/themotleyfool.svg', name='The Motley Fool')•2026-02-11
Why Hinge Health Stock Popped on WednesdayPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/investing.ico', homepage_url='https://www.investing.com/', logo_url='https://s3.massive.com/public/assets/news/logos/investing.png', name='Investing.com')•2026-01-05
Notable Newcomers: These 2025 IPOs Dominated the YearPublisher(favicon_url='https://s3.massive.com/public/assets/news/favicons/themotleyfool.ico', homepage_url='https://www.fool.com/', logo_url='https://s3.massive.com/public/assets/news/logos/themotleyfool.svg', name='The Motley Fool')•2025-12-04
Up 44% Since IPO: Why a Major Fund Just Made a $45 Million Bet on This Digital Health StockAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$0
Sell Value
$148M
Buys
0
Sells
47
Buy Value
$0
Sell Value
$148M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-21 | Mecklenburg Gabriel M.I. | C | 33,333 | $0.00 |
| 2026-04-21 | Mecklenburg Gabriel M.I. | Sell | 33,333 | $45.05 |
| 2026-04-21 | Mecklenburg Gabriel M.I. | C | 33,333 | $0.00 |
| 2026-04-05 | Sloat Tyler | A | 68 | $42.40 |
| 2026-04-01 | Mecklenburg Gabriel M.I. | C | 50,000 | $0.00 |
| 2026-04-01 | Mecklenburg Gabriel M.I. | Sell | 668 | $39.02 |
| 2026-04-01 | Mecklenburg Gabriel M.I. | Sell | 49,332 | $38.45 |
| 2026-04-01 | Mecklenburg Gabriel M.I. | C | 50,000 | $0.00 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1,038,742 | 0.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 732,586 | 0.01% | 2025-12-31 |
| Franklin Custodian Funds-FRANKLIN DYNATECH FUND | 600,000 | 0.01% | 2025-12-31 |
| BARON INVESTMENT Fd.S TRT -BARON SMALL CAP Fd. | 600,000 | 0.01% | 2025-12-31 |
| Vanguard Explorer Fund | 525,874 | 0.01% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 471,594 | 0.01% | 2025-12-31 |
| LORD ABBETT DEVELOPING GROWTH Fd., INC.-Lord Abbett Developing Growth | 429,764 | 0.01% | 2026-01-31 |
| BARON INVESTMENT Fd.S TRT -BARON OPPORTUNITY Fd. | 331,785 | 0.01% | 2025-12-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
Bank of New York Mellon
Filed 2026-02-10
--
--
Coatue Management
Filed 2026-02-17
--
--
Vanguard Group
Filed 2026-01-29
$121M
+110.5%
Tiger Global Management
Filed 2026-02-17
$84M
--
Marshall Wace
Filed 2026-02-13
$54M
--
Goldman Sachs
Filed 2026-02-10
$27M
+89.8%
Dark-pool activity snapshot
Analyst consensus?
Rating(?)
4.13
Consensus
BuyTarget Mean(?)
—
Target High(?)
—
Target Low(?)
—
Analysts
23
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.